A carregar...
Durlobactam, a New Diazabicyclooctane β-Lactamase Inhibitor for the Treatment of Acinetobacter Infections in Combination With Sulbactam
Durlobactam is a new member of the diazabicyclooctane class of β-lactamase inhibitors with broad spectrum activity against Ambler class A, C, and D serine β-lactamases. Sulbactam is a first generation β-lactamase inhibitor with activity limited to a subset of class A enzymes that also has direct-act...
Na minha lista:
| Publicado no: | Front Microbiol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8328114/ https://ncbi.nlm.nih.gov/pubmed/34349751 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmicb.2021.709974 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|